Hot-Spot-Guided Generative Deep Learning for Drug-Like PPI Inhibitor Design
Heqi Sun1, Jiayi Li1,2, Yufang Zhang3,4
1State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
None:
Protein-protein interactions (PPIs) are essential therapeutic targets, yet their large and relatively flat interfaces hinder the development of small-molecule inhibitors. Traditional computational approaches rely heavily on existing chemical libraries or expert heuristics, restricting exploration of novel chemical space. To address these challenges, we present Hot2Mol, a generative deep learning framework for the de novo design of target-specific and drug-like PPI inhibitors. Hot2Mol captures crucial pharmacophoric features from hot-spot residues, allowing precise targeting of PPI interfaces while eliminating the need for known bioactive ligands. The framework integrates three main components: a conditional transformer for pharmacophore-guided, property-constrained molecular generation; an E(n)-equivariant graph neural network to ensure accurate spatial alignment with PPI hot-spot pharmacophores; a variational autoencoder to sample novel and diverse molecular structures. Comprehensive assessments demonstrate that Hot2Mol outperforms state-of-the-art models in binding affinity, drug-likeness, synthetic accessibility, novelty, and uniqueness. Molecular dynamics simulations further confirm the strong binding stability of generated compounds. Case studies underscore Hot2Mol's ability to design high-affinity and selective PPI inhibitors, highlighting its potential to accelerate rational PPI-targeted drug discovery.
More Related Videos
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein-protein Interfaces
